Interferon Beta-1A News

← Back to News Overview


Interferon Beta-1A currently has 17 news articles, with 20 predicted indications.

This page combines the AI-predicted indications for Interferon Beta-1A with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
  • Original indication: Rebif is indicated for the treatment of: patients with a single demyelinating event with an active inflammatory process, if alternative diagnoses have been excluded, and if they are determined to be...
  • Evidence level: L5
  • Predicted indications (20):
    • relapsing-remitting multiple sclerosis (100.0%)
    • Jeune syndrome situs inversus (97.5%)
    • Pierre Robin syndrome associated with a chromosomal anomaly (97.3%)
    • partial deletion of the long arm of chromosome 22 (97.2%)
    • disorder of fucoglycosan synthesis (97.2%)
    • Laubry-Pezzi syndrome (97.2%)
    • partial deletion of the long arm of chromosome 7 (97.2%)
    • orofacial clefting syndrome (97.1%)
    • genetic syndromic Pierre Robin syndrome (97.1%)
    • rete ovarii cystadenoma (97.1%)
    • borderline ovarian serous tumor (97.1%)
    • ovarian benign neoplasm (97.0%)
    • ovarian papillary cystadenoma (97.0%)
    • ovarian mucinous cystadenofibroma (97.0%)
    • hairy cell leukemia (96.9%)
    • serous neoplasm (96.9%)
    • mucinous ovarian cystadenoma (96.8%)
    • malignant ovarian Brenner tumor (96.8%)
    • ovarian surface papilloma (96.8%)
    • autoimmune disease of central nervous system (96.8%)

View full drug report →

Imidazolpropionat aus dem Darm: möglicher Verstärker der Alzheimer-Pathologie - it boltwise

2026-10-11 diabetes MS

Source: it boltwise


¿Cómo detener la obesidad infantil que ya se cuadruplicó? - El Diario de Madryn

2026-10-11 obesidad MS

Source: El Diario de Madryn


‘American Covid’ rising in UK - pharmacist shares 12 symptoms to watch for - The Mirror

2026-10-11 MS

Source: The Mirror


Des scientifiques établissent la liste des 17 principales menaces pesant sur la santé humaine d’ici à 2100 - Le Monde.fr

2026-10-10 obésité MS

Source: Le Monde.fr


Mickaël Worms-Ehrminger, enseignant en santé publique : « Les réseaux sociaux contribuent à une glamourisation de certains troubles psychiatriques » - Le Monde.fr

2026-10-10 MS

Source: Le Monde.fr


El brote de ébola en el Congo supera los 4.200 muertos - La Tribuna de Albacete

2026-10-10 MS

Source: La Tribuna de Albacete


Retatrutide bei Diabetes: 52 Prozent verlieren mindestens 20 Prozent Gewicht - AD HOC NEWS

2026-10-10 diabetes MS

Source: AD HOC NEWS


Golden Retrievers Help Themselves to Ice From the Fridge Like It’s Their Personal Snack Bar

2026-10-10 MS

Source: PetHelpful


Ear-based nerve stimulation may boost hand rehab in people with MS - Multiple Sclerosis News Today

2026-10-10 multiple sclerosis

Source: Multiple Sclerosis News Today


Ocrelizumab bei RRMS: 82,2 Prozent bleiben zehn Jahre ohne Behinderungsprogression - AD HOC NEWS

2026-10-09 Ocrelizumab MS

Source: AD HOC NEWS


Grippe : le virus est déjà là, une mutation fait craindre le pire pour cet hiver !

2026-10-09 MS

Source: RA-sante.com


UKHSA confirms ‘stay at home’ rule for two Covid symptoms - Daily Express

2026-10-09 MS

Source: Daily Express


Teen’s life changed by gene editing that stopped blood disorder symptoms

2026-10-09 MS

Source: BBC


Urin- und Vaginalzytologie könnten Erkennung des Endometriumkarzinoms vereinfachen – News - Deutsches Ärzteblatt

2026-10-08 MS

Source: Deutsches Ärzteblatt


Nagging people to eat healthily does not work - The Economist

2026-10-08 obesity MS AF

Source: The Economist


Chronische Darmentzündung: Ein blockierter Energiestoffwechsel als Heilungsbremse - PTA IN LOVE

2026-10-07 MS

Source: PTA IN LOVE


Darum häufen sich „Zombie-Zellen“ mit zunehmendem Alter - Schwächelndes Zellrecycling bremst die Immunabwehr

2026-10-06 MS

Source: Scinexx


Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.

Copyright © 2026 藥提醒科技有限公司 (yao.care). For research purposes only. Not medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.